Preliminary evaluation of a monovalent antivenom targeting Cerastes cerastes envenomation in North Africa: feasibility and specificity assessment

Read full text Summarise with VIRAT
Authors: Nihal Mesmoudi, Salma Chakir, Khawla Ammouch, Reda Chahir, Hinde Aassila, Abdellah Moustaghfir, Mehdi Karkouri, Naoual Oukkache
Cited by: 0
References: 20

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

In 2017, the World Health Organization (WHO) recognized snakebite envenomation as a neglected disease yet the therapeutic effectiveness efficacy of available antivenoms remains insufficiently explored. This study offers a detailed analysis of Cerastes cerastes venom, focusing its toxicological properties and the development of specific targeted neutralizing antibodies. Through rigorous quality control and comprehensive efficacy testing, the antivenom demonstrated significant neutralizing activity against critical venom components, including hemorrhagic, edema-forming, and myotoxic effects while also mitigating tissue damage. Histological investigations further corroborated the antivenom’s protective capacity. These findings not only underscore the potential of the developed antivenom for clinical use but also provide essential insights for advancing antivenom production, refining its specificity, and enhancing its therapeutic efficacy in managing snake envenomations.

Fields of Study & Subjects

Venomous Animal Envenomation and Studies Amphibian and Reptile Biology Healthcare and Venom Research

Publication details

Journal / source
Frontiers in Pharmacology
Volume
17
Pages
1719611–1719611
Publication date
26 March 2026
Language
EN